Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Encephalitis Viruses, Tick-Borne | 3 | 2024 | 48 | 2.650 |
Why?
|
Encephalitis, Tick-Borne | 2 | 2024 | 45 | 1.130 |
Why?
|
Bacterial Proteins | 8 | 2023 | 3840 | 0.870 |
Why?
|
Central Nervous System Infections | 1 | 2024 | 61 | 0.850 |
Why?
|
Anti-Glomerular Basement Membrane Disease | 1 | 2022 | 41 | 0.810 |
Why?
|
Immunoglobulin Fc Fragments | 3 | 2022 | 287 | 0.800 |
Why?
|
Acinetobacter baumannii | 1 | 2023 | 123 | 0.800 |
Why?
|
Glycoside Hydrolases | 6 | 2023 | 135 | 0.790 |
Why?
|
alpha-L-Fucosidase | 1 | 2020 | 8 | 0.740 |
Why?
|
Fosfomycin | 2 | 2019 | 26 | 0.740 |
Why?
|
Molecular Dynamics Simulation | 3 | 2021 | 427 | 0.730 |
Why?
|
Genome, Viral | 1 | 2024 | 674 | 0.710 |
Why?
|
Fucose | 1 | 2020 | 122 | 0.700 |
Why?
|
Polysaccharides | 8 | 2023 | 1024 | 0.660 |
Why?
|
NAD | 1 | 2023 | 618 | 0.650 |
Why?
|
Klebsiella pneumoniae | 2 | 2019 | 253 | 0.640 |
Why?
|
Phylogeny | 1 | 2024 | 2843 | 0.550 |
Why?
|
Fever | 1 | 2024 | 1614 | 0.520 |
Why?
|
Antibodies, Bacterial | 2 | 2024 | 1479 | 0.510 |
Why?
|
Headache | 1 | 2024 | 1263 | 0.510 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 2017 | 446 | 0.490 |
Why?
|
Immunoglobulin G | 7 | 2024 | 4568 | 0.460 |
Why?
|
Escherichia coli Proteins | 2 | 2019 | 1058 | 0.450 |
Why?
|
Protein Conformation | 2 | 2021 | 3956 | 0.440 |
Why?
|
Shigella | 1 | 2014 | 69 | 0.430 |
Why?
|
Vibrio cholerae O1 | 1 | 2014 | 243 | 0.390 |
Why?
|
Antigens, Bacterial | 1 | 2017 | 1150 | 0.370 |
Why?
|
Drug Resistance, Bacterial | 2 | 2019 | 1063 | 0.370 |
Why?
|
Drug Resistance, Microbial | 1 | 2014 | 830 | 0.360 |
Why?
|
Escherichia coli | 3 | 2019 | 4214 | 0.330 |
Why?
|
Genetic Variation | 1 | 2024 | 6611 | 0.320 |
Why?
|
Catalytic Domain | 3 | 2020 | 699 | 0.310 |
Why?
|
Substrate Specificity | 6 | 2023 | 1751 | 0.310 |
Why?
|
Crystallography, X-Ray | 4 | 2021 | 1951 | 0.260 |
Why?
|
Glycosylation | 4 | 2022 | 1100 | 0.260 |
Why?
|
Streptococcus pyogenes | 4 | 2023 | 293 | 0.250 |
Why?
|
Antibodies, Monoclonal | 3 | 2022 | 9263 | 0.240 |
Why?
|
Deuterium | 1 | 2023 | 106 | 0.220 |
Why?
|
Acetylglucosaminidase | 1 | 2023 | 66 | 0.210 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2024 | 238 | 0.210 |
Why?
|
Epitopes | 2 | 2021 | 2528 | 0.210 |
Why?
|
Hydrolases | 1 | 2023 | 146 | 0.210 |
Why?
|
Anti-Bacterial Agents | 3 | 2019 | 7477 | 0.200 |
Why?
|
Interleukin-1 Receptor Accessory Protein | 1 | 2021 | 5 | 0.200 |
Why?
|
Serologic Tests | 1 | 2024 | 382 | 0.200 |
Why?
|
Deuterium Exchange Measurement | 2 | 2021 | 31 | 0.200 |
Why?
|
Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase | 1 | 2021 | 20 | 0.190 |
Why?
|
Microbial Sensitivity Tests | 3 | 2019 | 1967 | 0.190 |
Why?
|
Binding Sites, Antibody | 2 | 2021 | 340 | 0.180 |
Why?
|
New England | 1 | 2024 | 1058 | 0.180 |
Why?
|
Metagenomics | 1 | 2024 | 474 | 0.170 |
Why?
|
Specimen Handling | 1 | 2024 | 708 | 0.170 |
Why?
|
Immune Evasion | 1 | 2023 | 375 | 0.160 |
Why?
|
Immunoglobulin M | 1 | 2024 | 1528 | 0.160 |
Why?
|
Clinical Laboratory Techniques | 1 | 2024 | 747 | 0.160 |
Why?
|
Canada | 1 | 2024 | 2130 | 0.160 |
Why?
|
Kinetics | 3 | 2023 | 6329 | 0.160 |
Why?
|
Lyme Disease | 1 | 2024 | 630 | 0.150 |
Why?
|
Internationality | 1 | 2024 | 1008 | 0.150 |
Why?
|
History, 21st Century | 1 | 2024 | 1573 | 0.150 |
Why?
|
Mammals | 1 | 2023 | 1135 | 0.150 |
Why?
|
Travel | 1 | 2024 | 805 | 0.150 |
Why?
|
Complement C1q | 1 | 2017 | 93 | 0.140 |
Why?
|
Neisseria meningitidis | 1 | 2017 | 111 | 0.130 |
Why?
|
History, 20th Century | 1 | 2024 | 2766 | 0.130 |
Why?
|
Oligosaccharides | 1 | 2018 | 407 | 0.130 |
Why?
|
Interleukin-1beta | 1 | 2021 | 1027 | 0.130 |
Why?
|
Gene Expression Regulation, Bacterial | 2 | 2020 | 1137 | 0.120 |
Why?
|
Autoantibodies | 1 | 2022 | 2121 | 0.110 |
Why?
|
Antibodies | 1 | 2021 | 2421 | 0.110 |
Why?
|
Potassium | 1 | 2017 | 1315 | 0.110 |
Why?
|
Antibodies, Viral | 1 | 2024 | 3216 | 0.100 |
Why?
|
Drug Synergism | 1 | 2017 | 1760 | 0.100 |
Why?
|
Protein Multimerization | 1 | 2017 | 965 | 0.100 |
Why?
|
Bacteria | 1 | 2023 | 2216 | 0.100 |
Why?
|
Anti-Inflammatory Agents | 1 | 2021 | 1805 | 0.100 |
Why?
|
Sensitivity and Specificity | 2 | 2024 | 14729 | 0.100 |
Why?
|
Bangladesh | 1 | 2014 | 742 | 0.100 |
Why?
|
Protein Binding | 3 | 2021 | 9343 | 0.090 |
Why?
|
Humans | 17 | 2024 | 768166 | 0.090 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2024 | 3671 | 0.090 |
Why?
|
Pseudomonas aeruginosa | 1 | 2019 | 1276 | 0.090 |
Why?
|
Hydrolysis | 2 | 2023 | 646 | 0.080 |
Why?
|
Immunosuppressive Agents | 1 | 2022 | 4206 | 0.080 |
Why?
|
Animals | 4 | 2024 | 169246 | 0.080 |
Why?
|
Pyrazoles | 1 | 2019 | 2028 | 0.080 |
Why?
|
Drug Therapy, Combination | 1 | 2017 | 6316 | 0.070 |
Why?
|
Pyrimidines | 1 | 2019 | 3048 | 0.070 |
Why?
|
Urban Population | 1 | 2014 | 2046 | 0.060 |
Why?
|
Rural Population | 1 | 2014 | 2325 | 0.050 |
Why?
|
Borrelia burgdorferi | 1 | 2024 | 183 | 0.050 |
Why?
|
Antibody Affinity | 1 | 2021 | 252 | 0.050 |
Why?
|
Immunoassay | 1 | 2024 | 746 | 0.040 |
Why?
|
Mannose | 1 | 2020 | 122 | 0.040 |
Why?
|
Antibody Specificity | 1 | 2021 | 1065 | 0.040 |
Why?
|
Trichoderma | 1 | 2018 | 9 | 0.040 |
Why?
|
Streptomyces | 1 | 2018 | 91 | 0.040 |
Why?
|
Carbohydrate Sequence | 1 | 2018 | 411 | 0.040 |
Why?
|
Thermodynamics | 1 | 2018 | 591 | 0.030 |
Why?
|
Mutation | 1 | 2020 | 30238 | 0.030 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2018 | 451 | 0.030 |
Why?
|
Molecular Structure | 1 | 2020 | 1883 | 0.030 |
Why?
|
Amino Acid Motifs | 1 | 2018 | 930 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2023 | 2202 | 0.030 |
Why?
|
Retrospective Studies | 1 | 2024 | 81762 | 0.030 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2019 | 591 | 0.030 |
Why?
|
Isoenzymes | 1 | 2018 | 1688 | 0.030 |
Why?
|
Cloning, Molecular | 1 | 2018 | 4168 | 0.030 |
Why?
|
Adult | 2 | 2024 | 223646 | 0.030 |
Why?
|
HEK293 Cells | 1 | 2021 | 4283 | 0.030 |
Why?
|
Vibrio cholerae | 1 | 2018 | 793 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2830 | 0.020 |
Why?
|
Models, Molecular | 1 | 2020 | 5403 | 0.020 |
Why?
|
Computational Biology | 1 | 2021 | 3568 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2018 | 3402 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2018 | 6514 | 0.020 |
Why?
|
Male | 1 | 2024 | 364719 | 0.020 |
Why?
|
Gene Expression | 1 | 2018 | 7598 | 0.020 |
Why?
|
Algorithms | 1 | 2024 | 14164 | 0.010 |
Why?
|
Signal Transduction | 1 | 2021 | 23645 | 0.010 |
Why?
|
United States | 1 | 2024 | 73039 | 0.010 |
Why?
|
Middle Aged | 1 | 2024 | 223492 | 0.010 |
Why?
|
Female | 1 | 2024 | 397192 | 0.000 |
Why?
|
Concepts
(123)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(15)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_